PharmaCyte Biotech Income Statement (2010-2026) | PMCB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Apr2021	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	0.32M	0.14M	0.14M	0.16M	0.25M	0.16M	0.18M	0.05M	0.09M	0.10M	0.08M	0.13M	0.09M	0.10M	0.10M	0.12M	0.13M	0.10M	0.14M	0.09M
Wages, Salaries and Other (Quarter)	0.26M	0.27M	0.28M	0.27M	0.01M	0.33M	0.10M	0.10M	316.00	0.33M	0.23M	0.62M	0.33M	0.14M	0.28M	0.23M
Selling, General & Administrative (Quarter)	0.13M	0.36M	0.26M	0.22M	0.25M	0.24M	0.18M	0.36M	0.33M	1.36M	0.27M	0.25M	4.23M	1.17M	1.01M	0.84M	0.92M	0.75M	1.23M	2.02M
Other Operating Expenses (Quarter)	0.59M	0.52M	0.61M	0.48M	1.00M	1.28M	1.96M	1.15M	0.49M	0.62M	1.05M	1.49M	-1.16M
Operating Expenses (Quarter)	1.03M	1.02M	1.00M	0.86M	1.51M	1.68M	2.32M	1.55M	0.90M	2.08M	1.41M	1.87M	3.17M	1.27M	1.11M	0.96M	1.04M	0.85M	1.38M	2.12M
Operating Income (Quarter)	-1.03M	-1.02M	-1.00M	-0.86M	-1.51M	-1.68M	-2.32M	-1.55M	-0.90M	-2.08M	-1.41M	-1.87M	-3.17M	-1.27M	-1.11M	-0.96M	-1.04M	-0.85M	-1.38M	-2.12M
EBIT (Quarter)	-1.03M	-1.02M	-1.00M	-0.86M	-1.51M	-1.68M	-2.32M	-1.55M	-0.90M	-2.08M	-1.41M	-1.87M	-3.17M	-1.27M	-1.11M	-0.96M	-1.04M	-0.85M	-1.38M	-2.12M
Non-operating items
Non Operating Investment Income (Quarter)																0.07M	-0.01M	-0.10M	-0.06M	-0.13M
Interest & Investment Income (Quarter)			0.03M	0.05M	0.09M	0.14M	0.44M	0.64M	0.72M	0.88M	0.89M	0.88M	0.75M	0.55M	0.38M	0.26M	0.23M	0.22M	0.21M	0.23M
Other Non Operating Income (Quarter)	0.07M	-0.00M	0.03M	-630.00	-0.00M	-0.00M		0.15M	-0.15M	-1.45M	4.08M	-253.00	3.35M	-190.00	-0.00M	4.49M	10.45M	-121.00	-95.00	1.90M
Non Operating Income (Quarter)	0.07M	-0.00M	0.03M	0.04M	0.16M	-0.00M	0.44M	0.15M	0.05M	-1.11M	-765.00	-253.00	8.86M	24.69M	-0.36M	-400.00	-113.00	-7.51M	-6.04M	-632.00
Net income details
EBT (Quarter)	-1.03M	-1.02M	-0.98M	-0.81M	-1.42M	-1.55M	-1.88M	-0.92M	-0.18M	-1.20M	-0.52M	-0.99M	-2.42M	-0.72M	-0.72M	-0.70M	-0.81M	-0.63M	-1.17M	-1.89M
Profit After Tax (Quarter)	-0.96M	-1.03M	-0.98M	-0.81M	-1.42M	-1.55M	-1.88M	-0.76M	-0.13M	-3.18M	2.79M	-0.62M	1.35M	23.42M	-1.47M	-3.05M	11.75M	-8.36M	-7.42M	0.75M
Income from Non-Controlling Interests (Quarter)											-2.26M	-5.62M			-2.96M	-3.05M
Income from Continuing Operations (Quarter)	-1.03M	-1.02M	-0.98M	-0.81M	-1.42M	-1.55M	-1.88M	-0.92M	-0.18M	-1.20M	-0.52M	-0.99M	-2.42M	-0.72M	-0.72M	-0.70M	-0.81M	-0.63M	-1.17M	-1.89M
Consolidated Net Income (Quarter)	-1.03M	-1.02M	-0.98M	-0.81M	-1.42M	-1.55M	-1.88M	-0.92M	-0.18M	-1.20M	-0.52M	-0.99M	-2.42M	-0.72M	-0.72M	-0.70M	-0.81M	-0.63M	-1.17M	-1.89M
Income towards Parent Company (Quarter)	-1.03M	-1.02M	-0.98M	-0.81M	-1.42M	-1.55M	-1.88M	-0.92M	-0.18M	-1.20M	-0.52M	-0.99M	-2.42M	-0.72M	-0.72M	-0.70M	-0.81M	-0.63M	-1.17M	-1.89M
Preferred Dividend Payments (Quarter)										3.27M	0.59M	0.78M	-9.48M	0.69M	0.44M				0.10M	2.20M
Net Income towards Common Stockholders (Quarter)	-1.03M	-1.02M	-0.98M	-0.81M	-1.42M	-1.55M	-1.88M	-0.76M	-0.13M	-6.78M	-2.26M	-5.62M	-2.54M	20.59M	-2.96M	-3.05M	8.78M	-8.36M	-8.42M	-1.56M
Additional items
EPS (Basic) (Quarter)	-0.61	-0.64	-0.06	-0.04	-0.06	-0.07	-0.09	-0.04	-0.01	-0.28	-0.26	-0.65	-0.33	1.90	-0.39	-0.44	1.52	-1.23	-1.24	-0.17
EPS (Weighted Average and Diluted) (Quarter)	-0.71	-0.64	-0.06	-0.04	-0.06	-0.07	-0.09	-0.04	-0.01	-0.28	-0.21	-0.65	-0.33	1.90	-0.39	-0.44	1.52	-1.23	-1.24	-0.17
Shares Outstanding (Weighted Average) (Quarter)	0.00M	1.59M	9.47M	13.54M	10.77M	20.83M	20.59M	19.00M	9.89M	12.60M	8.77M	9.99M	9.58M	7.87M	7.75M	7.49M	18.57M	19.23M	6.80M	55.82M
Shares Outstanding (Diluted Average) (Quarter)	1.45M	1.59M	9.47M	13.54M	15.52M	20.83M	20.59M	19.00M	19.49M	12.60M	10.68M	8.61M	9.58M	7.87M	7.64M	6.96M	7.33M	6.80M	6.80M	7.62M
EBITDA (Quarter)	-1.03M	-1.02M	-1.00M	-0.86M	-1.51M	-1.68M	-2.32M	-1.55M	-0.90M	-2.08M	-1.41M	-1.87M	-3.17M	-1.27M	-1.11M	-0.96M	-1.04M	-0.85M	-1.38M	-2.12M
Interest Expenses (Quarter)		0.00M	42.00			0.00M
Shares Outstanding (Quarter)	1.59M	1.61M	20.72M	20.72M	20.72M	21.60M	-2.08M			0.04M	0.03M	0.02M	21.67M	0.01M		21.67M	21.67M			10.74M

Research Tools

PharmaCyte Biotech Income Statement (2010-2026) | PMCB

Create an account

Sign In

Reset Password